Cover Image
市場調查報告書

微流體市場分析:各用途 (醫藥品,基因學,蛋白質體學,細胞型化驗其他,體外診斷,POC,臨床,環境,工業,醫療設備) 、各材料及市場區隔預測

Microfluidics Market Analysis by Application (Pharmaceutical, Genomics, Proteomics, Cell Based Assays and Others, In Vitro Diagnostics, POC, Clinical, Environmental and Industrial, Medical Devices), by Material, and Segment Forecasts to 2024

出版商 Grand View Research, Inc. 商品編碼 370429
出版日期 內容資訊 英文 80 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
微流體市場分析:各用途 (醫藥品,基因學,蛋白質體學,細胞型化驗其他,體外診斷,POC,臨床,環境,工業,醫療設備) 、各材料及市場區隔預測 Microfluidics Market Analysis by Application (Pharmaceutical, Genomics, Proteomics, Cell Based Assays and Others, In Vitro Diagnostics, POC, Clinical, Environmental and Industrial, Medical Devices), by Material, and Segment Forecasts to 2024
出版日期: 2016年09月05日 內容資訊: 英文 80 Pages
簡介

本報告提供全球微流體市場相關調查,彙整市場各用途,各材料別趨勢,今後預測,及加入此市場的主要企業簡介等資料。

第1章 調查方法與調查範圍

第2章 摘要整理

第3章 市場概要

第4章 市場變數,趨勢,範圍

  • 市場區隔和範圍
    • 推動市場的要素分析
    • 阻礙市場的要素分析
  • 滲透度與成長預測製圖
  • 因素別SWOT分析
  • 產業分析:波特五力分析

第5章 市場分類1:各用途預測與趨勢分析

  • 各用途趨勢分析
  • 醫藥品
  • 體外診斷
  • 醫療設備

第6章 市場分類2:各材料預測與趨勢分析

  • 各材料趨勢分析
  • 聚合物
  • 玻璃
  • 金屬,陶瓷,其他

第7章 市場分類3:各地區預測與趨勢分析

  • 各地區市場佔有率
  • 北美
  • 歐洲
  • 亞太地區
  • 南美
  • 中東·非洲

第8章 競爭環境

  • 策略架構
  • 市場進入分類
  • 企業簡介
    • Illumina, Inc.
    • Agilent Technologies
    • Caliper Life Sciences
    • Cepheid
    • Danaher Corporation
    • Life Technologies Corporation
    • Bio-Rad Laboratories
    • Abbott Laboratories
    • F. Hoffmann-La Roche Ltd
    • Fluidigm Corporation

圖表

目錄
Product Code: GVR-1-68038-056-9

The global microfluidics market is expected to reach USD 10 billion by 2024, according to a new report by Grand View Research, Inc. The demand for this sector is expected to upsurge due to the introduction of improved technology, such as digital microfluidics, which enables on-chip biochemical analysis.

Industry players are introducing newer sampling technologies to meet the demand for screening a huge number of biological samples. For instance, in March 2014, Dolomite launched Mitos Dropix capable of generating miniature droplets to isolate contents. The patented droplet picking technology enables high-throughput sample screening.

Moreover, researchers are continuously striving to come up with improved sample droplet production techniques. For instance, Columbia University introduced the picoliter fluid dispensation technology. This lab-on-chip technology could deliver sample volume less than 50 nL. Integrating microfluidics with multiplexed sensing technology allows multiple sample analytical application.

Further Key Findings From the Study Suggests:

In Vitro Diagnostic (IVD) segment dominated the application segment owing to the increasing adoption of microfluidics in this market. Moreover, the leaders in the diagnostics sector, such as Abbott, Roche, and Danaher are encouraging the use of newer microfluidics technologies, such as the monodisperse bubbles/drops.

Novel drug delivery system requires the administration of the drug in the form of nanoparticles, thereby reducing the onset of action. Devices such as microneedles, pumps, and inhalers are expected to experience fastest growth during the forecasted period.

Polymers had the largest revenue share in 2015. Polymers offer better temperature control as compared to glass. However, silicon material is expected to witness fastest growth owing to the dominance of point-of-care diagnostics in the microfluidics market. Moreover, the growing demands for faster results with minimally invasive tools are expected to boost growth of this sector.

North America dominated the market in 2015. It is attributed to the presence of strong research capital, introduction of improved sample volume screening techniques, and presence of dominant market players.

In June 2016, Roche received 510 (K) clearances for Elecsys BRAHMS PCT assay. With this launch, Roche became the only company to offer integrated solutions: the assessment and management of sepsis risk. The biomarker was developed to offer a solution for the 1.6 million annual hospitalizations.

Asia Pacific is expected to witness fastest growth owing to the increasing aging population, repeated hospital visits, presence of untapped market, and the low cost of labor. These factors have attracted many international players to establish their research laboratories in India and China.

The industry is also experiencing many mergers and acquisitions between competitors. In July 2015, IDEX Corporation acquired CIDRA Precision Services, LLC. CIDRA Precision Services, LLC is a manufacturer of microfluidics devices and the acquisition is expected to accelerate IDEX growth in the microfluidics space.

Some key players are Illumina, Inc.; Agilent Technologies; Caliper Life Sciences (acquired by PerkinElmer, Inc.); Cepheid; Danaher Corporation; Life Technologies Corporation (acquired by Thermo Fisher Scientific, Inc.);Bio-Rad Laboratories, Inc.; Abbott Laboratories; F. Hoffmann-La Roche Ltd; and Fluidigm Corporation.

Table of Contents

Chapter 1: Research Methodology & Scope

  • 1.1. Region Wise Market Calculation
    • 1.1.1. Region Wise Market: Base Estimates
    • 1.1.2. Global Market: CAGR Calculation
  • 1.2. Region Based Segment Share Calculation
  • 1.3. List of Secondary Sources

Chapter 2: Executive Summary

Chapter 3: Market Snapshot

Chapter 4: Market Variables, Trends & Scope

  • 4.1. Market Segmentation & Scope
    • 4.1.1. Market Driver Analysis
      • 4.1.1.1. Incresing demand for low-volume sample analysis
      • 4.1.1.2. Growing penetration of microfluidics in the diagnostics market
      • 4.1.1.3. Introcution of advanced technologies
    • 4.1.2. Market Restraint Analysis
      • 4.1.2.1. High operational cost
      • 4.1.2.2. Complex fabriation process
  • 4.2. Penetration & Growth Prospect Mapping
  • 4.3. Microfluidics-SWOT Analysis, By Factor(Political & Legal, Economic And Technological)
  • 4.4. Industry Analysis-Porter's

Chapter 5: Market Categorization 1: Application Estimates & Trend Analysis

  • 5.1. Microfluidics Market: Application Movement Analysis
  • 5.2. Pharmaceutical Microfluidics
    • 5.2.1. Global Pharmaceutical Microfluidics Market, 2013-2024(USD Million)
      • 5.2.1.1. Global Genomics Microfluidics Market, 2013-2024(USD Million)
      • 5.2.1.2. Global Proteomics Microfluidics Market, 2013-2024(USD Million)
      • 5.2.1.3. Global Cell Based Assays and Others Microfluidics Market, 2013-2024(USD Million)
  • 5.3. In-Vitro Diagnostics(IVD) Microfluidics
    • 5.3.1. Global In-Vitro Diagnostics(IVD) Microfluidics Market, 2013-2024(USD Million)
      • 5.3.1.1. Global Point-of-Care(POC) Microfluidics Market, 2013-2024(USD Million)
      • 5.3.1.2. Global Clinical Microfluidics Market, 2013-2024(USD Million)
      • 5.3.1.3. Global Environental and Industrial Microfluidics Market, 2013-2024(USD Million)
  • 5.4. Medical Devices Microfluidics

Chapter 6: Market Categorization 2: Material Estimates & Trend Analysis

  • 6.1. Microfluidics Market: Material Movement Analysis
  • 6.2. Polymer Microfluidics
    • 6.2.1. Global Polymer Microfluidics Market, 2013-2024(USD Million)
  • 6.3. Glass Microfluidics
    • 6.3.1. Global Glass Microfluidics Market, 2013-2024(USD Million)
  • 6.4. Silicon Microfluidics
    • 6.4.1. Global Silicon Microfluidics Market, 2013-2024(USD Million)
  • 6.5. Metal, Ceramics and Others Microfluidics
    • 6.5.1. Global Metal, Ceramics and Others Microfluidics Market, 2013-2024(USD Million)

Chapter 7: Market Categorization 3: Regional Estimates & Trend Analysis, by Service

  • 7.1. Microfluidics Market Share By Region, 2015 & 2024
  • 7.2. North America
    • 7.2.1. North America Microfluidics Market, 2013-2024(USD Million)
    • 7.2.2. U.S.
      • 7.2.2.1. U.S. Microfluidics Market, 2013-2024(USD Million)
    • 7.2.3. Canada
      • 7.2.3.1. Canada Microfluidics Market, 2013-2024(USD Million)
  • 7.3. Europe
    • 7.3.1. Europe Microfluidics Market, 2013-2024(USD Million
    • 7.3.2. Germany
      • 7.3.2.1. Germany Microfluidics Market, 2013-2024(USD Million)
    • 7.3.3. UK
      • 7.3.3.1. UK Microfluidics Market, 2013-2024(USD Million)
    • 7.3.4. France
      • 7.3.4.1. France Microfluidics Market, 2013-2024(USD Million)
  • 7.4. Asia Pacific.
    • 7.4.1. Asia Pacific Microfluidics Market, 2013-2024(USD Million)
    • 7.4.2. Japan
      • 7.4.2.1. Japan Microfluidics Market, 2013-2024(USD Million)
    • 7.4.3. China
      • 7.4.3.1. China Microfluidics Market, 2013-2024(USD Million)
    • 7.4.4. India
      • 7.4.4.1. India Microfluidics Market, 2013-2024(USD Million)
  • 7.5. Latin America
    • 7.5.1. Latin America Microfluidics Market, 2013-2024(USD Million)
    • 7.5.2. Brazil
      • 7.5.2.1. Brazil Microfluidics Market, 2013-2024(USD Million)
    • 7.5.3. Mexico
      • 7.5.3.1. Mexico Microfluidics Market, 2013-2024(USD Million)
  • 7.6. Middle East & Africa.
    • 7.6.1. Middle East & Africa Microfluidics Market, 2013-2024(USD Million)
    • 7.6.2. South Africa
      • 7.6.2.1. South Africa Microfluidics Market, 2013-2024(USD Million)

Chapter 8: Competitive Landscape

  • 8.1. Strategy framework
  • 8.2. Market participation categorization
  • 8.3. Company Profiles
    • 8.3.1. Illumina, Inc.
      • 8.3.1.1. Company Overview
      • 8.3.1.2. Financial Performance
      • 8.3.1.3. Product Benchmarking
      • 8.3.1.4. Strategic Initiatives
    • 8.3.2. Agilent Technologies
      • 8.3.2.1. Company Overview
      • 8.3.2.2. Financial Performance
      • 8.3.2.3. Product Benchmarking
      • 8.3.2.4. Strategic Initiatives
    • 8.3.3. Caliper Life Sciences
      • 8.3.3.1. Company Overview
      • 8.3.3.2. Financial Performance
      • 8.3.3.3. Product Benchmarking
      • 8.3.3.4. Strategic Initiatives
    • 8.3.4. Cepheid
      • 8.3.4.1. Company Overview
      • 8.3.4.2. Financial Performance
      • 8.3.4.3. Product Benchmarking
      • 8.3.4.4. Strategic Initiatives
    • 8.3.5. Danaher Corporation
      • 8.3.5.1. Company Overview
      • 8.3.5.2. Financial Performance
      • 8.3.5.3. Product Benchmarking
      • 8.3.5.4. Strategic Initiatives
    • 8.3.6. Life Technologies Corporation
      • 8.3.6.1. Company Overview
      • 8.3.6.2. Financial Performance
      • 8.3.6.3. Product Benchmarking
      • 8.3.6.4. Strategic Initiatives
    • 8.3.7. Bio-Rad Laboratories
      • 8.3.7.1. Company Overview
      • 8.3.7.2. Financial Performance
      • 8.3.7.3. Product Benchmarking
      • 8.3.7.4. Strategic Initiatives
    • 8.3.8. Abbott Laboratories
      • 8.3.8.1. Company Overview
      • 8.3.8.2. Financial Performance
      • 8.3.8.3. Product Benchmarking
      • 8.3.8.4. Strategic Initiatives
    • 8.3.9. F. Hoffmann-La Roche Ltd
      • 8.3.9.1. Company Overview
      • 8.3.9.2. Financial Performance
      • 8.3.9.3. Product Benchmarking
      • 8.3.9.4. Strategic Initiatives
    • 8.3.10. Fluidigm Corporation
      • 8.3.10.1. Company Overview
      • 8.3.10.2. Financial Performance
      • 8.3.10.3. Product Benchmarking
      • 8.3.10.4. Strategic Initiatives

List of Tables

  • TABLE 1: Country Share Estimation
  • TABLE 2: North America Microfluidics Market Estimates And Forecasts, By Application, 2013 - 2024 (USD Million)
  • TABLE 3: North America Microfluidics Pharmaceutical Market Estimates And Forecasts, By Application, 2013 - 2024 (USD Million)
  • TABLE 4: North America Microfluidics In-Vitro Diagnostic (IVD) Market Estimates And Forecasts, By Application, 2013 - 2024 (USD Million)
  • TABLE 5: North America Microfluidics Medical Devices Market Estimates And Forecasts, By Application, 2013 - 2024 (USD Million)
  • TABLE 6: North America Microfluidics Market Estimates And Forecasts, By Material, 2013 - 2024 (USD Million)
  • TABLE 7: U.S. Microfluidics Market Estimates And Forecasts, By Application, 2013 - 2024 (USD Million)
  • TABLE 8: U.S. Microfluidics Pharmaceutical Market Estimates And Forecasts, By Application, 2013 - 2024 (USD Million)
  • TABLE 9: U.S. Microfluidics In-Vitro Diagnostic (IVD) Market Estimates And Forecasts, By Application, 2013 - 2024 (USD Million)
  • TABLE 10: U.S. Microfluidics Medical Devices Market Estimates And Forecasts, By Application, 2013 - 2024 (USD Million)
  • TABLE 11: U.S. Microfluidics Market Estimates And Forecasts, By Material, 2013 - 2024 (USD Million)
  • TABLE 12: Canada Microfluidics Market Estimates And Forecasts, By Application, 2013 - 2024 (USD Million)
  • TABLE 13: Canada Microfluidics Pharmaceutical Market Estimates And Forecasts, By Application, 2013 - 2024 (USD Million)
  • TABLE 14: Canada Microfluidics In-Vitro Diagnostic (IVD) Market Estimates And Forecasts, By Application, 2013 - 2024 (USD Million)
  • TABLE 15: Canada Microfluidics Medical Devices Market Estimates And Forecasts, By Application, 2013 - 2024 (USD Million)
  • TABLE 16: Canada Microfluidics Market Estimates And Forecasts, By Material, 2013 - 2024 (USD Million)
  • TABLE 17: Europe Microfluidics Market Estimates And Forecasts, By Application, 2013 - 2024 (USD Million)
  • TABLE 18: Europe Microfluidics Pharmaceutical Market Estimates And Forecasts, By Application, 2013 - 2024 (USD Million)
  • TABLE 19: Europe Microfluidics In-Vitro Diagnostic (IVD) Market Estimates And Forecasts, By Application, 2013 - 2024 (USD Million)
  • TABLE 20: Europe Microfluidics Medical Devices Market Estimates And Forecasts, By Application, 2013 - 2024 (USD Million)
  • TABLE 21: Europe Microfluidics Market Estimates And Forecasts, By Material, 2013 - 2024 (USD Million)
  • TABLE 22: UK Microfluidics Market Estimates And Forecasts, By Application, 2013 - 2024 (USD Million)
  • TABLE 23: UK Microfluidics Pharmaceutical Market Estimates And Forecasts, By Application, 2013 - 2024 (USD Million)
  • TABLE 24: UK Microfluidics In-Vitro Diagnostic (IVD) Market Estimates And Forecasts, By Application, 2013 - 2024 (USD Million)
  • TABLE 25: UK Microfluidics Medical Devices Market Estimates And Forecasts, By Application, 2013 - 2024 (USD Million)
  • TABLE 26: UK Microfluidics Market Estimates And Forecasts, By Material, 2013 - 2024 (USD Million)
  • TABLE 27: France Microfluidics Market Estimates And Forecasts, By Application, 2013 - 2024 (USD Million)
  • TABLE 28: France Microfluidics Pharmaceutical Market Estimates And Forecasts, By Application, 2013 - 2024 (USD Million)
  • TABLE 29: France Microfluidics In-Vitro Diagnostic (IVD) Market Estimates And Forecasts, By Application, 2013 - 2024 (USD Million)
  • TABLE 30: France Microfluidics Medical Devices Market Estimates And Forecasts, By Application, 2013 - 2024 (USD Million)
  • TABLE 31: France Microfluidics Market Estimates And Forecasts, By Material, 2013 - 2024 (USD Million)
  • TABLE 32: Germany Microfluidics Market Estimates And Forecasts, By Application, 2013 - 2024 (USD Million)
  • TABLE 33: Germany Microfluidics Pharmaceutical Market Estimates And Forecasts, By Application, 2013 - 2024 (USD Million)
  • TABLE 34: Germany Microfluidics In-Vitro Diagnostic (IVD) Market Estimates And Forecasts, By Application, 2013 - 2024 (USD Million)
  • TABLE 35: Germany Microfluidics Medical Devices Market Estimates And Forecasts, By Application, 2013 - 2024 (USD Million)
  • TABLE 36: Germany Microfluidics Market Estimates And Forecasts, By Material, 2013 - 2024 (USD Million)
  • TABLE 37: APAC Microfluidics Market Estimates And Forecasts, By Application, 2013 - 2024 (USD Million)
  • TABLE 38: APAC Microfluidics Pharmaceutical Market Estimates And Forecasts, By Application, 2013 - 2024 (USD Million)
  • TABLE 39: APAC Microfluidics In-Vitro Diagnostic (IVD) Market Estimates And Forecasts, By Application, 2013 - 2024 (USD Million)
  • TABLE 40: APAC Microfluidics Medical Devices Market Estimates And Forecasts, By Application, 2013 - 2024 (USD Million)
  • TABLE 41: APAC Microfluidics Market Estimates And Forecasts, By Material, 2013 - 2024 (USD Million)
  • TABLE 42: India Microfluidics Market Estimates And Forecasts, By Application, 2013 - 2024 (USD Million)
  • TABLE 43: India Microfluidics Pharmaceutical Market Estimates And Forecasts, By Application, 2013 - 2024 (USD Million)
  • TABLE 44: India Microfluidics In-Vitro Diagnostic (IVD) Market Estimates And Forecasts, By Application, 2013 - 2024 (USD Million)
  • TABLE 45: India Microfluidics Medical Devices Market Estimates And Forecasts, By Application, 2013 - 2024 (USD Million)
  • TABLE 46: India Microfluidics Market Estimates And Forecasts, By Material, 2013 - 2024 (USD Million)
  • TABLE 47: China Microfluidics Market Estimates And Forecasts, By Application, 2013 - 2024 (USD Million)
  • TABLE 48: China Microfluidics Pharmaceutical Market Estimates And Forecasts, By Application, 2013 - 2024 (USD Million)
  • TABLE 49: China Microfluidics In-Vitro Diagnostic (IVD) Market Estimates And Forecasts, By Application, 2013 - 2024 (USD Million)
  • TABLE 50: China Microfluidics Medical Devices Market Estimates And Forecasts, By Application, 2013 - 2024 (USD Million)
  • TABLE 51: China Microfluidics Market Estimates And Forecasts, By Material, 2013 - 2024 (USD Million)
  • TABLE 52: Japan Microfluidics Market Estimates And Forecasts, By Application, 2013 - 2024 (USD Million)
  • TABLE 53: Japan Microfluidics Pharmaceutical Market Estimates And Forecasts, By Application, 2013 - 2024 (USD Million)
  • TABLE 54: Japan Microfluidics In-Vitro Diagnostic (IVD) Market Estimates And Forecasts, By Application, 2013 - 2024 (USD Million)
  • TABLE 55: Japan Microfluidics Medical Devices Market Estimates And Forecasts, By Application, 2013 - 2024 (USD Million)
  • TABLE 56: Japan Microfluidics Market Estimates And Forecasts, By Material, 2013 - 2024 (USD Million)
  • TABLE 57: Latin America Microfluidics Market Estimates And Forecasts, By Application, 2013 - 2024 (USD Million)
  • TABLE 58: Latin America Microfluidics Pharmaceutical Market Estimates And Forecasts, By Application, 2013 - 2024 (USD Million)
  • TABLE 59: Latin America Microfluidics In-Vitro Diagnostic (IVD) Market Estimates And Forecasts, By Application, 2013 - 2024 (USD Million)
  • TABLE 60: Latin America Microfluidics Medical Devices Market Estimates And Forecasts, By Application, 2013 - 2024 (USD Million)
  • TABLE 61: Latin America Microfluidics Market Estimates And Forecasts, By Material, 2013 - 2024 (USD Million)
  • TABLE 62: Brazil Microfluidics Market Estimates And Forecasts, By Application, 2013 - 2024 (USD Million)
  • TABLE 63: Brazil Microfluidics Pharmaceutical Market Estimates And Forecasts, By Application, 2013 - 2024 (USD Million)
  • TABLE 64: Brazil Microfluidics In-Vitro Diagnostic (IVD) Market Estimates And Forecasts, By Application, 2013 - 2024 (USD Million)
  • TABLE 65: Brazil Microfluidics Medical Devices Market Estimates And Forecasts, By Application, 2013 - 2024 (USD Million)
  • TABLE 66: Brazil Microfluidics Market Estimates And Forecasts, By Material, 2013 - 2024 (USD Million)
  • TABLE 67: Mexico Microfluidics Market Estimates And Forecasts, By Application, 2013 - 2024 (USD Million)
  • TABLE 68: Mexico Microfluidics Pharmaceutical Market Estimates And Forecasts, By Application, 2013 - 2024 (USD Million)
  • TABLE 69: Mexico Microfluidics In-Vitro Diagnostic (IVD) Market Estimates And Forecasts, By Application, 2013 - 2024 (USD Million)
  • TABLE 70: Mexico Microfluidics Medical Devices Market Estimates And Forecasts, By Application, 2013 - 2024 (USD Million)
  • TABLE 71: Mexico Microfluidics Market Estimates And Forecasts, By Material, 2013 - 2024 (USD Million)
  • TABLE 72: MEA Microfluidics Market Estimates And Forecasts, By Application, 2013 - 2024 (USD Million)
  • TABLE 73: MEA Microfluidics Pharmaceutical Market Estimates And Forecasts, By Application, 2013 - 2024 (USD Million)
  • TABLE 74: MEA Microfluidics In-Vitro Diagnostic (IVD) Market Estimates And Forecasts, By Application, 2013 - 2024 (USD Million)
  • TABLE 75: MEA Microfluidics Medical Devices Market Estimates And Forecasts, By Application, 2013 - 2024 (USD Million)
  • TABLE 76: MEA Microfluidics Market Estimates And Forecasts, By Material, 2013 - 2024 (USD Million)
  • TABLE 77: South Africa Microfluidics Market Estimates And Forecasts, By Application, 2013 - 2024 (USD Million)
  • TABLE 78: South Africa Microfluidics Pharmaceutical Market Estimates And Forecasts, By Application, 2013 - 2024 (USD Million)
  • TABLE 79: South Africa Microfluidics In-Vitro Diagnostic (IVD) Market Estimates And Forecasts, By Application, 2013 - 2024 (USD Million)
  • TABLE 80: South Africa Microfluidics Medical Devices Market Estimates And Forecasts, By Application, 2013 - 2024 (USD Million)
  • TABLE 81: South Africa Microfluidics Market Estimates And Forecasts, By Material, 2013 - 2024 (USD Million)

List of Figures

  • Fig. 1: Market Summary
  • Fig. 2: Market Trends & Outlook
  • Fig. 3: Market Segmentation & Scope
  • Fig. 4: Market Driver Relevance Analysis (Current & Future Impact)
  • Fig. 5: Market Restraint Relevance Analysis (Current & Future Impact)
  • Fig. 6: Penetration & Growth Prospect Mapping
  • Fig. 7: SWOT Analysis, By Factor (Political & Legal, Economic And Technological)
  • Fig. 8: Porter's Five Forces Analysis
  • Fig. 9: Microfluidics Market Application Outlook Key Takeaways
  • Fig. 10: Microfluidics Market: Application Movement Analysis
  • Fig. 11: Global Microfluidics Market, by Application 2013 - 2024 (USD Million)
  • Fig. 12: Global Microfluidics Pharmaceutical Market, 2013 - 2024 (USD Million)
  • Fig. 13: Global Microfluidics Genomics Market, 2013 - 2024 (USD Million)
  • Fig. 14: Global Microfluidics Proteomics Market, 2013 - 2024 (USD Million)
  • Fig. 15: Global Microfluidics Cell Based Assays and Others Market, 2013 - 2024 (USD Million)
  • Fig. 16: Global Microfluidics In-Vitro Diagnostics (IVD) Market, 2013 - 2024 (USD Million)
  • Fig. 17: Global Microfluidics Point-of-Care (POC) Market, 2013 - 2024 (USD Million)
  • Fig. 18: Global Microfluidics Clinical Market, 2013 - 2024 (USD Million)
  • Fig. 19: Global Microfluidics Environmental and industrial Market, 2013 - 2024 (USD Million)
  • Fig. 20: Global Microfluidics Medical Devices Market, 2013 - 2024 (USD Million)
  • Fig. 21: Global Microfluidics Market, by Material 2013 - 2024 (USD Million)
  • Fig. 22: Global Polymer Microfluidics 2013 - 2024 (USD Million)
  • Fig. 23: Global Glass Microfluidics Market 2013 - 2024 (USD Million)
  • Fig. 24: Global Siliocn Microfluidics Market 2013 - 2024 (USD Million)
  • Fig. 25: Global Metal, Ceramic and Others Microfluidics Market 2013 - 2024 (USD Million)
  • Fig. 26: Regional Market Place: Key Takeaways
  • Fig. 27: Microfluidcis Regional Outlook, 2015 & 2024
  • Fig. 28: North America Microfluidics Market, 2013 - 2024 (USD Million)
  • Fig. 29: U.S. Microfluidics Market, 2013 - 2024 (USD Million)
  • Fig. 30: Canada Microfluidics Market, 2013 - 2024 (USD Million)
  • Fig. 31: Europe Microfluidics Market, 2013 - 2024 (USD Million)
  • Fig. 32: Germany. Microfluidics Market, 2013 - 2024 (USD Million)
  • Fig. 33: Uk. Microfluidics Market, 2013 - 2024 (USD Million)
  • Fig. 34: France. Microfluidics Market, 2013 - 2024 (USD Million)
  • Fig. 35: Asia Pacific. Microfluidics Market, 2013 - 2024 (USD Million)
  • Fig. 36: Japan. Microfluidics Market, 2013 - 2024 (USD Million)
  • Fig. 37: China. Microfluidics Market, 2013 - 2024 (USD Million)
  • Fig. 38: India Microfluidics Market, 2013 - 2024 (USD Million)
  • Fig. 39: Latin America. Microfluidics Market, 2013 - 2024 (USD Million)
  • Fig. 40: Brazil. Microfluidics Market, 2013 - 2024 (USD Million)
  • Fig. 41: Mexico Microfluidics Market, 2013 - 2024 (USD Million
  • Fig. 42: Middle East & Africa. Microfluidics Market, 2013 - 2024 (USD Million)
  • Fig. 43: South Africa Microfluidics Market, 2013 - 2024 (USD Million)
  • Fig. 44: Strategy Framework
  • Fig. 45: Participant Categorization
Back to Top